Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin

Click to increase image sizeClick to decrease image size

Disclosure statement

No competing financial interests exist.

Funding information

No funding was received for this study.

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Additional information

Notes on contributors

Matteo Boattini

Matteo Boattini is Internal Medicine specialist and Microbiology fellow at the University Hospital Città della Salute e della Scienza di Torino, Italy.

Gabriele Bianco

Gabriele Bianco is microbiologist at the University Hospital Città della Salute e della Scienza di Torino, Italy.

Marco Iannaccone

Marco Iannaccone is microbiologist at the University Hospital Città della Salute e della Scienza di Torino, Italy.

Alessandro Bondi

Alessandro Bondi is Microbiology fellow at the University Hospital Città della Salute e della Scienza di Torino, Italy.

Rossana Cavallo

Rossana Cavallo is Professor in Clinical Microbiology at the University Hospital Città della Salute e della Scienza di Torino, Italy.

Cristina Costa

Cristina Costa is Professor in Clinical Microbiology at the University Hospital Città della Salute e della Scienza di Torino, Italy.